Generic Name: Ticagrelor
Brand Name: Brilinta
Manufacturer: AstraZeneca Canada Inc
Indications: Acute Coronary Syndromes (ACS)
Submission Type: Pre-NOC
Project Status: Cancelled
Ticagrelor
Last Updated: June 8, 2010
Result type: Reports
Project Number: S0203
Product Line: Common Drug Review